Cohen Klingenstein LLC Viatris Inc Transaction History
Cohen Klingenstein LLC
- $2.68 Billion
- Q1 2025
A detailed history of Cohen Klingenstein LLC transactions in Viatris Inc stock. As of the latest transaction made, Cohen Klingenstein LLC holds 18,354 shares of VTRS stock, worth $154,540. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,354
Previous 18,354
-0.0%
Holding current value
$154,540
Previous $228,000
30.26%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding VTRS
# of Institutions
1,122Shares Held
990MCall Options Held
2.18MPut Options Held
1.68M-
Vanguard Group Inc Valley Forge, PA142MShares$1.2 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$780 Million0.02% of portfolio
-
State Street Corp Boston, MA63.7MShares$537 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$527 Million4.62% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD58.7MShares$494 Million0.08% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $10.2B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...